Literature DB >> 15246760

A rapid and repeatable method for venom extraction from cubozoan nematocysts.

T Carrette1, J Seymour.   

Abstract

Various comparative studies into the biological activity and relative toxicity of cubozoan venoms have been investigated, in particular the venom from the potentially lethal cubozoan Chironex fleckeri. Efficient and reliable extraction of venom from nematocysts is essential before any research into venom toxicity can be conducted and previous cited methods of extraction have varied greatly, each with their own associated problems. A new standardised technique for the recovery of venom from nematocysts of cubozoans is investigated to decrease the variation displayed between authors due to differing extraction techniques. The use of a mini bead mill beater, as investigated in this trial, allows for the rapid extraction of venom from nematocysts and is devoid of the previously isolated problems experienced with other methods of venom isolation, such as excessive heat build up.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246760     DOI: 10.1016/j.toxicon.2004.04.008

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  22 in total

1.  Neurotoxin localization to ectodermal gland cells uncovers an alternative mechanism of venom delivery in sea anemones.

Authors:  Yehu Moran; Grigory Genikhovich; Dalia Gordon; Stefanie Wienkoop; Claudia Zenkert; Suat Ozbek; Ulrich Technau; Michael Gurevitz
Journal:  Proc Biol Sci       Date:  2011-11-02       Impact factor: 5.349

2.  Proteomic Changes during the Dermal Toxicity Induced by Nemopilema nomurai Jellyfish Venom in HaCaT Human Keratinocyte.

Authors:  Indu Choudhary; Duhyeon Hwang; Jinho Chae; Wonduk Yoon; Changkeun Kang; Euikyung Kim
Journal:  Toxins (Basel)       Date:  2021-04-27       Impact factor: 4.546

3.  Firing the sting: chemically induced discharge of cnidae reveals novel proteins and peptides from box jellyfish (Chironex fleckeri) venom.

Authors:  Mahdokht Jouiaei; Nicholas R Casewell; Angel A Yanagihara; Amanda Nouwens; Bronwen W Cribb; Darryl Whitehead; Timothy N W Jackson; Syed A Ali; Simon C Wagstaff; Ivan Koludarov; Paul Alewood; Jay Hansen; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2015-03-18       Impact factor: 4.546

4.  Pharmacological studies of tentacle extract from the jellyfish Cyanea capillata in isolated rat aorta.

Authors:  Beilei Wang; Bo Zhang; Qianqian Wang; Zhi Zhang; Fei Nie; Guoyan Liu; Jiemin Zheng; Liang Xiao; Liming Zhang
Journal:  Mar Drugs       Date:  2013-08-30       Impact factor: 5.118

5.  In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai.

Authors:  Seong Kyeong Bae; Hyunkyoung Lee; Yunwi Heo; Min Jung Pyo; Indu Choudhary; Chang Hoon Han; Won Duk Yoon; Changkeun Kang; Euikyung Kim
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-07-19

6.  Intervention effects of five cations and their correction on hemolytic activity of tentacle extract from the jellyfish Cyanea capillata.

Authors:  Hui Zhang; Qianqian Wang; Liang Xiao; Liming Zhang
Journal:  PeerJ       Date:  2017-05-09       Impact factor: 2.984

7.  protective effect of tetracycline against dermal toxicity induced by Jellyfish venom.

Authors:  Changkeun Kang; Yeung Bae Jin; Jeongsoo Kwak; Hongseok Jung; Won Duk Yoon; Tae-Jin Yoon; Jong-Shu Kim; Euikyung Kim
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

8.  Cubozoan venom-induced cardiovascular collapse is caused by hyperkalemia and prevented by zinc gluconate in mice.

Authors:  Angel A Yanagihara; Ralph V Shohet
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Dose and time dependence of box jellyfish antivenom.

Authors:  Athena Andreosso; Michael J Smout; Jamie E Seymour
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-08-12

Review 10.  Jellyfish Bioactive Compounds: Methods for Wet-Lab Work.

Authors:  Bárbara Frazão; Agostinho Antunes
Journal:  Mar Drugs       Date:  2016-04-12       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.